HomeCompareKSU vs MRK

KSU vs MRK: Dividend Comparison 2026

KSU yields 37.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KSU wins by $12.05M in total portfolio value
10 years
KSU
KSU
● Live price
37.81%
Share price
$293.59
Annual div
$111.01
5Y div CAGR
24.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.10M
Annual income
$7,585,466.37
Full KSU calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KSU vs MRK

📍 KSU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKSUMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KSU + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KSU pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KSU
Annual income on $10K today (after 15% tax)
$3,214.09/yr
After 10yr DRIP, annual income (after tax)
$6,447,646.41/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KSU beats the other by $6,439,318.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KSU + MRK for your $10,000?

KSU: 50%MRK: 50%
100% MRK50/50100% KSU
Portfolio after 10yr
$6.08M
Annual income
$3,797,632.25/yr
Blended yield
62.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KSU
Analyst Ratings
18
Buy
16
Hold
2
Sell
Consensus: Buy
Price Target
$300.00
+2.2% upside vs current
Range: $300.00 — $300.00
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KSU buys
0
MRK buys
0
No recent congressional trades found for KSU or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKSUMRK
Forward yield37.81%2.76%
Annual dividend / share$111.01$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR24.2%32.7%
Portfolio after 10y$12.10M$56.8K
Annual income after 10y$7,585,466.37$9,798.13
Total dividends collected$11.59M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$300.00$128.54

Year-by-year: KSU vs MRK ($10,000, DRIP)

YearKSU PortfolioKSU Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,396$4,696.35$11,206$366.19+$4.2KKSU
2$24,867$8,392.99$12,650$502.35+$12.2KKSU
3$42,343$15,734.80$14,407$694.19+$27.9KKSU
4$76,406$31,099.38$16,585$967.82+$59.8KKSU
5$146,893$65,138.72$19,342$1,363.89+$127.6KKSU
6$302,538$145,362.13$22,913$1,947.19+$279.6KKSU
7$671,225$347,509.98$27,662$2,823.89+$643.6KKSU
8$1,613,151$894,939.99$34,159$4,173.35+$1.58MKSU
9$4,222,611$2,496,539.45$43,337$6,308.80+$4.18MKSU
10$12,103,660$7,585,466.37$56,776$9,798.13+$12.05MKSU

KSU vs MRK: Complete Analysis 2026

KSUStock

Kansas City Southern, a transportation holding company, provides domestic and international rail transportation services in North America. The company serves a ten-state region in the midwest and southeast regions of the United States and has the shortest north/south rail route between Kansas City, Missouri, and ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas. It operates a commercial corridor of the Mexican railroad system and has its direct rail passageway between Mexico City and Laredo, Texas. The company provides rail access to the United States and Mexico border crossing at Nuevo Laredo, Tamaulipas; and controls and operates the southern half of the rail bridge at Laredo, Texas, as well as the northern half of this bridge. Kansas City Southern also provides rail access to the port of Lazaro Cardenas on the Pacific Ocean; and owns a 157-mile rail line extending from Laredo, Texas to the port city of Corpus Christi, Texas. Its rail network comprises approximately 6,700 route miles extending from the Midwest and Southeast portions of the United States south into Mexico. The company serves the chemical and petroleum, industrial and consumer products, agriculture and minerals, energy, intermodal, and automotive markets. Kansas City Southern was founded in 1887 and is headquartered in Kansas City, Missouri.

Full KSU Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KSU vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KSU vs SCHDKSU vs JEPIKSU vs OKSU vs KOKSU vs MAINKSU vs JNJKSU vs ABBVKSU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.